#METABOLOMICS WORKBENCH trubel_20250529_094230 DATATRACK_ID:5963 STUDY_ID:ST003984 ANALYSIS_ID:AN006562 PROJECT_ID:PR002493
VERSION             	1
CREATED_ON             	June 16, 2025, 8:09 pm
#PROJECT
PR:PROJECT_TITLE                 	Metabolome analysis as a potential source of endometriosis biomarkers
PR:PROJECT_SUMMARY               	This project aims to analyse the metabolomic profiles of plasma and peritoneal
PR:PROJECT_SUMMARY               	fluid samples obtained from women with endometriosis and compare them to those
PR:PROJECT_SUMMARY               	of the control group. It involves the collection of samples from women
PR:PROJECT_SUMMARY               	undergoing laparoscopic surgery in several medical centres.
PR:INSTITUTE                     	Calisia University
PR:DEPARTMENT                    	Women’s Health Research Institute
PR:LAST_NAME                     	Wojtyła
PR:FIRST_NAME                    	Cezary
PR:ADDRESS                       	Nowy Świat 4, 62-800 Kalisz, Poland
PR:EMAIL                         	c.wojtyla@uniwersytetkaliski.edu.pl
PR:PHONE                         	+48 62 76 79 500
#STUDY
ST:STUDY_TITLE                   	Metabolome analysis as a potential source of endometriosis biomarkers with the
ST:STUDY_TITLE                   	use of multiomics approach in its diagnosis
ST:STUDY_SUMMARY                 	This study aimed to analyse the metabolomic profiles of plasma and peritoneal
ST:STUDY_SUMMARY                 	fluid samples obtained from women with endometriosis compared to controls. Our
ST:STUDY_SUMMARY                 	multicenter study involved sample collection from women undergoing laparoscopic
ST:STUDY_SUMMARY                 	surgery. The metabolomic profiles of plasma samples obtained from 73 women with
ST:STUDY_SUMMARY                 	endometriosis and 35 controls and peritoneal fluid (PF) samples from 53 women
ST:STUDY_SUMMARY                 	with endometriosis and 34 controls were analysed using mass spectrometry
ST:STUDY_SUMMARY                 	techniques. Statistical testing identified five lipids in PF and one in plasma,
ST:STUDY_SUMMARY                 	exhibiting significant differences between the endometriosis and control groups.
ST:STUDY_SUMMARY                 	Importantly, phosphatidylcholine (PC ae C30:2) level was consistently increased
ST:STUDY_SUMMARY                 	in both sample sources. Additional chemometric PLS-DA analyses identified a set
ST:STUDY_SUMMARY                 	of 20 metabolites present in PF and 26 compounds in plasma, which differentiate
ST:STUDY_SUMMARY                 	women with endometriosis and the control group among samples collected during
ST:STUDY_SUMMARY                 	the luteal phase of the menstrual cycle (AUC equal to 0.84 in PF and 0.95 in
ST:STUDY_SUMMARY                 	plasma). We also used a simple approach to build a classification model based on
ST:STUDY_SUMMARY                 	the sets of metabolites in combination with autoantibodies selected using
ST:STUDY_SUMMARY                 	protein microarrays from our previous study. The classification performance
ST:STUDY_SUMMARY                 	obtained on the joined metabolomic and proteomic feature sets exceeds that
ST:STUDY_SUMMARY                 	achievable for separate assays.
ST:INSTITUTE                     	Calisia University
ST:DEPARTMENT                    	Women’s Health Research Institute
ST:LAST_NAME                     	Wojtyła
ST:FIRST_NAME                    	Cezary
ST:ADDRESS                       	Nowy Świat 4, 62-800 Kalisz, Poland
ST:EMAIL                         	c.wojtyla@uniwersytetkaliski.edu.pl
ST:PHONE                         	+48 62 76 79 500
#SUBJECT
SU:SUBJECT_TYPE                  	Human
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
SU:GENDER                        	Female
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	KA11	1044481404	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=6; Age=34; RAW_FILE_NAME=KIT3-0-8115_1044482286_91_0_1_1_00_1044481404.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_91_0_1_1_00_1044481404.raw
SUBJECT_SAMPLE_FACTORS           	KA1	1044481419	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=11; Age=34; RAW_FILE_NAME=KIT3-0-8115_1044482286_08_0_1_1_00_1044481419.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_08_0_1_1_00_1044481419.raw
SUBJECT_SAMPLE_FACTORS           	KA9	1044481423	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=13; Age=33; RAW_FILE_NAME=KIT3-0-8115_1044482286_20_0_1_1_00_1044481423.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_20_0_1_1_00_1044481423.raw
SUBJECT_SAMPLE_FACTORS           	KA19	1044481438	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=5; Age=27; RAW_FILE_NAME=KIT3-0-8115_1044482286_32_0_1_1_00_1044481438.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_32_0_1_1_00_1044481438.raw
SUBJECT_SAMPLE_FACTORS           	KA12	1044481442	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=11; Age=33; RAW_FILE_NAME=KIT3-0-8115_1044482286_44_0_1_1_00_1044481442.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_44_0_1_1_00_1044481442.raw
SUBJECT_SAMPLE_FACTORS           	KA5	1044481457	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=13; Age=26; RAW_FILE_NAME=KIT3-0-8115_1044482286_56_0_1_1_00_1044481457.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_56_0_1_1_00_1044481457.raw
SUBJECT_SAMPLE_FACTORS           	KA6	1044481461	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=7; Age=35; RAW_FILE_NAME=KIT3-0-8115_1044482286_68_0_1_1_00_1044481461.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_68_0_1_1_00_1044481461.raw
SUBJECT_SAMPLE_FACTORS           	KI1	1044481476	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482271-1   1044482286-1; Cycle day=19; Age=41; RAW_FILE_NAME=KIT3-0-8115_1044482286_80_0_1_1_00_1044481476.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_80_0_1_1_00_1044481476.raw
SUBJECT_SAMPLE_FACTORS           	KI2	1044481481	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=11; Age=30; RAW_FILE_NAME=KIT3-0-8115_1044482286_92_0_1_1_00_1044481481.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_92_0_1_1_00_1044481481.raw
SUBJECT_SAMPLE_FACTORS           	KI16	1044481495	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Batch=1044482271-1   1044482286-1; Cycle day=19; Age=21; RAW_FILE_NAME=KIT3-0-8115_1044482286_09_0_1_1_00_1044481495.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_09_0_1_1_00_1044481495.raw
SUBJECT_SAMPLE_FACTORS           	KI10	1044481506	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482271-1   1044482286-1; Cycle day=20; Age=34; RAW_FILE_NAME=KIT3-0-8115_1044482286_21_0_1_1_00_1044481506.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_21_0_1_1_00_1044481506.raw
SUBJECT_SAMPLE_FACTORS           	KI20	1044481511	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=13; Age=28; RAW_FILE_NAME=KIT3-0-8115_1044482286_33_0_1_1_00_1044481511.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_33_0_1_1_00_1044481511.raw
SUBJECT_SAMPLE_FACTORS           	KI14	1044481714	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=10; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482286_45_0_1_1_00_1044481714.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_45_0_1_1_00_1044481714.raw
SUBJECT_SAMPLE_FACTORS           	RZ3	1044481729	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482271-1   1044482286-1; Cycle day=25; Age=31; RAW_FILE_NAME=KIT3-0-8115_1044482286_57_0_1_1_00_1044481729.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_57_0_1_1_00_1044481729.raw
SUBJECT_SAMPLE_FACTORS           	RZ10	1044481733	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Batch=1044482271-1   1044482286-1; Cycle day=21; Age=35; RAW_FILE_NAME=KIT3-0-8115_1044482286_69_0_1_1_00_1044481733.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_69_0_1_1_00_1044481733.raw
SUBJECT_SAMPLE_FACTORS           	RZ2	1044481748	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=10; Age=38; RAW_FILE_NAME=KIT3-0-8115_1044482286_81_0_1_1_00_1044481748.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_81_0_1_1_00_1044481748.raw
SUBJECT_SAMPLE_FACTORS           	PR29	1044481752	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482271-1   1044482286-1; Cycle day=7; Age=35; RAW_FILE_NAME=KIT3-0-8115_1044482286_93_0_1_1_00_1044481752.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_93_0_1_1_00_1044481752.raw
SUBJECT_SAMPLE_FACTORS           	Wu1	1044481767	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482271-1   1044482286-1; Cycle day=17; Age=30; RAW_FILE_NAME=KIT3-0-8115_1044482286_10_0_1_1_00_1044481767.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_10_0_1_1_00_1044481767.raw
SUBJECT_SAMPLE_FACTORS           	WU40	1044481771	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482271-1   1044482286-1; Cycle day=15; Age=40; RAW_FILE_NAME=KIT3-0-8115_1044482286_22_0_1_1_00_1044481771.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_22_0_1_1_00_1044481771.raw
SUBJECT_SAMPLE_FACTORS           	Wu41	1044481786	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=12; Age=45; RAW_FILE_NAME=KIT3-0-8115_1044482286_34_0_1_1_00_1044481786.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_34_0_1_1_00_1044481786.raw
SUBJECT_SAMPLE_FACTORS           	KI19	1044481791	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482271-1   1044482286-1; Cycle day=24; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482286_46_0_1_1_00_1044481791.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_46_0_1_1_00_1044481791.raw
SUBJECT_SAMPLE_FACTORS           	KI7	1044481801	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=7; Age=28; RAW_FILE_NAME=KIT3-0-8115_1044482286_58_0_1_1_00_1044481801.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_58_0_1_1_00_1044481801.raw
SUBJECT_SAMPLE_FACTORS           	KI3	1044481816	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=10; Age=33; RAW_FILE_NAME=KIT3-0-8115_1044482286_70_0_1_1_00_1044481816.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_70_0_1_1_00_1044481816.raw
SUBJECT_SAMPLE_FACTORS           	Ki4.19	1044481821	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482271-1   1044482286-1; Cycle day=26; Age=25; RAW_FILE_NAME=KIT3-0-8115_1044482286_82_0_1_1_00_1044481821.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_82_0_1_1_00_1044481821.raw
SUBJECT_SAMPLE_FACTORS           	KA13	1044481835	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=9; Age=30; RAW_FILE_NAME=KIT3-0-8115_1044482286_94_0_1_1_00_1044481835.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_94_0_1_1_00_1044481835.raw
SUBJECT_SAMPLE_FACTORS           	KA16	1044481840	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=6; Age=33; RAW_FILE_NAME=KIT3-0-8115_1044482286_11_0_1_1_00_1044481840.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_11_0_1_1_00_1044481840.raw
SUBJECT_SAMPLE_FACTORS           	KA3	1044481854	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=14; Age=36; RAW_FILE_NAME=KIT3-0-8115_1044482286_23_0_1_1_00_1044481854.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_23_0_1_1_00_1044481854.raw
SUBJECT_SAMPLE_FACTORS           	KI1.19	1044481869	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=14; Age=32; RAW_FILE_NAME=KIT3-0-8115_1044482286_35_0_1_1_00_1044481869.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_35_0_1_1_00_1044481869.raw
SUBJECT_SAMPLE_FACTORS           	KI3.19	1044481873	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=5; Age=21; RAW_FILE_NAME=KIT3-0-8115_1044482286_47_0_1_1_00_1044481873.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_47_0_1_1_00_1044481873.raw
SUBJECT_SAMPLE_FACTORS           	KI12	1044481888	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=13; Age=35; RAW_FILE_NAME=KIT3-0-8115_1044482286_59_0_1_1_00_1044481888.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_59_0_1_1_00_1044481888.raw
SUBJECT_SAMPLE_FACTORS           	PR2	1044481892	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=13; Age=35; RAW_FILE_NAME=KIT3-0-8115_1044482286_71_0_1_1_00_1044481892.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_71_0_1_1_00_1044481892.raw
SUBJECT_SAMPLE_FACTORS           	PR21	1044481903	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=12; Age=19; RAW_FILE_NAME=KIT3-0-8115_1044482286_83_0_1_1_00_1044481903.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_83_0_1_1_00_1044481903.raw
SUBJECT_SAMPLE_FACTORS           	WU6	1044481918	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482271-1   1044482286-1; Cycle day=16; Age=33; RAW_FILE_NAME=KIT3-0-8115_1044482286_95_0_1_1_00_1044481918.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_95_0_1_1_00_1044481918.raw
SUBJECT_SAMPLE_FACTORS           	KI5	1044481922	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482271-1   1044482286-1; Cycle day=17; Age=34; RAW_FILE_NAME=KIT3-0-8115_1044482286_12_0_1_1_00_1044481922.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_12_0_1_1_00_1044481922.raw
SUBJECT_SAMPLE_FACTORS           	KI8	1044481937	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=16; Age=30; RAW_FILE_NAME=KIT3-0-8115_1044482286_24_0_1_1_00_1044481937.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_24_0_1_1_00_1044481937.raw
SUBJECT_SAMPLE_FACTORS           	PR25	1044481941	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=5; Age=19; RAW_FILE_NAME=KIT3-0-8115_1044482286_36_0_1_1_00_1044481941.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_36_0_1_1_00_1044481941.raw
SUBJECT_SAMPLE_FACTORS           	PR15	1044481956	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482271-1   1044482286-1; Cycle day=13; Age=39; RAW_FILE_NAME=KIT3-0-8115_1044482286_48_0_1_1_00_1044481956.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_48_0_1_1_00_1044481956.raw
SUBJECT_SAMPLE_FACTORS           	PR8	1044481961	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482271-1   1044482286-1; Cycle day=21; Age=27; RAW_FILE_NAME=KIT3-0-8115_1044482286_60_0_1_1_00_1044481961.raw; RAW_FILE_NAME=KIT2-0-8115_1044482271_60_0_1_1_00_1044481961.raw
SUBJECT_SAMPLE_FACTORS           	RZ4	1044481994	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=11; Age=26; RAW_FILE_NAME=KIT3-0-8115_1044482267_74_0_1_1_00_1044481994.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_74_0_1_1_00_1044481994.raw
SUBJECT_SAMPLE_FACTORS           	RZ9	1044482006	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=8; Age=26; RAW_FILE_NAME=KIT3-0-8115_1044482267_86_0_1_1_00_1044482006.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_86_0_1_1_00_1044482006.raw
SUBJECT_SAMPLE_FACTORS           	PR14	1044482011	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=9; Age=39; RAW_FILE_NAME=KIT3-0-8115_1044482267_03_0_1_1_00_1044482011.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_03_0_1_1_00_1044482011.raw
SUBJECT_SAMPLE_FACTORS           	PR13	1044482025	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=26; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482267_15_0_1_1_00_1044482025.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_15_0_1_1_00_1044482025.raw
SUBJECT_SAMPLE_FACTORS           	PO6	1044482030	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=30; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482267_27_0_1_1_00_1044482030.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_27_0_1_1_00_1044482030.raw
SUBJECT_SAMPLE_FACTORS           	WM4	1044482044	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=16; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482267_39_0_1_1_00_1044482044.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_39_0_1_1_00_1044482044.raw
SUBJECT_SAMPLE_FACTORS           	PR31	1044482059	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=5; Age=24; RAW_FILE_NAME=KIT3-0-8115_1044482267_51_0_1_1_00_1044482059.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_51_0_1_1_00_1044482059.raw
SUBJECT_SAMPLE_FACTORS           	PO12	1044482063	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:IV | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=10; Age=30; RAW_FILE_NAME=KIT3-0-8115_1044482267_63_0_1_1_00_1044482063.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_63_0_1_1_00_1044482063.raw
SUBJECT_SAMPLE_FACTORS           	KI4	1044482078	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=12; Age=37; RAW_FILE_NAME=KIT3-0-8115_1044482267_75_0_1_1_00_1044482078.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_75_0_1_1_00_1044482078.raw
SUBJECT_SAMPLE_FACTORS           	PR6	1044481525	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=10; Age=32; RAW_FILE_NAME=KIT3-0-8115_1044482267_87_0_1_1_00_1044481525.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_87_0_1_1_00_1044481525.raw
SUBJECT_SAMPLE_FACTORS           	PR3	1044481530	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=25; Age=27; RAW_FILE_NAME=KIT3-0-8115_1044482267_04_0_1_1_00_1044481530.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_04_0_1_1_00_1044481530.raw
SUBJECT_SAMPLE_FACTORS           	KA14	1044481544	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=9; Age=37; RAW_FILE_NAME=KIT3-0-8115_1044482267_16_0_1_1_00_1044481544.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_16_0_1_1_00_1044481544.raw
SUBJECT_SAMPLE_FACTORS           	WU32	1044481559	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=8; Age=28; RAW_FILE_NAME=KIT3-0-8115_1044482267_28_0_1_1_00_1044481559.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_28_0_1_1_00_1044481559.raw
SUBJECT_SAMPLE_FACTORS           	WU16	1044481563	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=10; Age=39; RAW_FILE_NAME=KIT3-0-8115_1044482267_40_0_1_1_00_1044481563.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_40_0_1_1_00_1044481563.raw
SUBJECT_SAMPLE_FACTORS           	WU33	1044481578	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=10; Age=27; RAW_FILE_NAME=KIT3-0-8115_1044482267_52_0_1_1_00_1044481578.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_52_0_1_1_00_1044481578.raw
SUBJECT_SAMPLE_FACTORS           	WU34	1044481582	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=17; Age=34; RAW_FILE_NAME=KIT3-0-8115_1044482267_64_0_1_1_00_1044481582.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_64_0_1_1_00_1044481582.raw
SUBJECT_SAMPLE_FACTORS           	WU7	1044481597	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=6; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482267_76_0_1_1_00_1044481597.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_76_0_1_1_00_1044481597.raw
SUBJECT_SAMPLE_FACTORS           	RZ7	1044481608	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:IV | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=12; Age=33; RAW_FILE_NAME=KIT3-0-8115_1044482267_88_0_1_1_00_1044481608.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_88_0_1_1_00_1044481608.raw
SUBJECT_SAMPLE_FACTORS           	WU35	1044481612	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=10; Age=37; RAW_FILE_NAME=KIT3-0-8115_1044482267_05_0_1_1_00_1044481612.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_05_0_1_1_00_1044481612.raw
SUBJECT_SAMPLE_FACTORS           	PO4	1044481627	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=11; Age=30; RAW_FILE_NAME=KIT3-0-8115_1044482267_17_0_1_1_00_1044481627.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_17_0_1_1_00_1044481627.raw
SUBJECT_SAMPLE_FACTORS           	PO9	1044481631	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=20; Age=34; RAW_FILE_NAME=KIT3-0-8115_1044482267_29_0_1_1_00_1044481631.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_29_0_1_1_00_1044481631.raw
SUBJECT_SAMPLE_FACTORS           	PO10	1044481646	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:II | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=22; Age=39; RAW_FILE_NAME=KIT3-0-8115_1044482267_41_0_1_1_00_1044481646.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_41_0_1_1_00_1044481646.raw
SUBJECT_SAMPLE_FACTORS           	PO3	1044481651	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=11; Age=32; RAW_FILE_NAME=KIT3-0-8115_1044482267_53_0_1_1_00_1044481651.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_53_0_1_1_00_1044481651.raw
SUBJECT_SAMPLE_FACTORS           	PO13	1044481665	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:II | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=17; Age=28; RAW_FILE_NAME=KIT3-0-8115_1044482267_65_0_1_1_00_1044481665.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_65_0_1_1_00_1044481665.raw
SUBJECT_SAMPLE_FACTORS           	PO11	1044481670	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=16; Age=28; RAW_FILE_NAME=KIT3-0-8115_1044482267_77_0_1_1_00_1044481670.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_77_0_1_1_00_1044481670.raw
SUBJECT_SAMPLE_FACTORS           	PR24	1044481684	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=20; Age=20; RAW_FILE_NAME=KIT3-0-8115_1044482267_89_0_1_1_00_1044481684.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_89_0_1_1_00_1044481684.raw
SUBJECT_SAMPLE_FACTORS           	PR18	1044481699	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=12; Age=28; RAW_FILE_NAME=KIT3-0-8115_1044482267_06_0_1_1_00_1044481699.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_06_0_1_1_00_1044481699.raw
SUBJECT_SAMPLE_FACTORS           	RZ6	1044481700	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=21; Age=28; RAW_FILE_NAME=KIT3-0-8115_1044482267_18_0_1_1_00_1044481700.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_18_0_1_1_00_1044481700.raw
SUBJECT_SAMPLE_FACTORS           	PR20	1044480564	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=8; Age=40; RAW_FILE_NAME=KIT3-0-8115_1044482267_30_0_1_1_00_1044480564.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_30_0_1_1_00_1044480564.raw
SUBJECT_SAMPLE_FACTORS           	LO15	1044480579	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=14; Age=25; RAW_FILE_NAME=KIT3-0-8115_1044482267_42_0_1_1_00_1044480579.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_42_0_1_1_00_1044480579.raw
SUBJECT_SAMPLE_FACTORS           	WM1	1044480583	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=11; Age=41; RAW_FILE_NAME=KIT3-0-8115_1044482267_54_0_1_1_00_1044480583.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_54_0_1_1_00_1044480583.raw
SUBJECT_SAMPLE_FACTORS           	WM2	1044480598	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=16; Age=31; RAW_FILE_NAME=KIT3-0-8115_1044482267_66_0_1_1_00_1044480598.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_66_0_1_1_00_1044480598.raw
SUBJECT_SAMPLE_FACTORS           	WU12	1044480609	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=9; Age=40; RAW_FILE_NAME=KIT3-0-8115_1044482267_78_0_1_1_00_1044480609.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_78_0_1_1_00_1044480609.raw
SUBJECT_SAMPLE_FACTORS           	WU11	1044480613	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=11; Age=32; RAW_FILE_NAME=KIT3-0-8115_1044482267_90_0_1_1_00_1044480613.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_90_0_1_1_00_1044480613.raw
SUBJECT_SAMPLE_FACTORS           	PR30	1044480628	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=17; Age=33; RAW_FILE_NAME=KIT3-0-8115_1044482267_07_0_1_1_00_1044480628.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_07_0_1_1_00_1044480628.raw
SUBJECT_SAMPLE_FACTORS           	WU13	1044480632	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=11; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482267_19_0_1_1_00_1044480632.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_19_0_1_1_00_1044480632.raw
SUBJECT_SAMPLE_FACTORS           	WU14	1044480647	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=10; Age=34; RAW_FILE_NAME=KIT3-0-8115_1044482267_31_0_1_1_00_1044480647.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_31_0_1_1_00_1044480647.raw
SUBJECT_SAMPLE_FACTORS           	KI15	1044480651	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=13; Age=40; RAW_FILE_NAME=KIT3-0-8115_1044482267_43_0_1_1_00_1044480651.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_43_0_1_1_00_1044480651.raw
SUBJECT_SAMPLE_FACTORS           	KI18	1044480666	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=17; Age=26; RAW_FILE_NAME=KIT3-0-8115_1044482267_55_0_1_1_00_1044480666.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_55_0_1_1_00_1044480666.raw
SUBJECT_SAMPLE_FACTORS           	PR1	1044480671	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=8; Age=21; RAW_FILE_NAME=KIT3-0-8115_1044482267_79_0_1_1_00_1044480671.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_79_0_1_1_00_1044480671.raw
SUBJECT_SAMPLE_FACTORS           	KA2	1044480685	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=10; Age=38; RAW_FILE_NAME=KIT3-0-8115_1044482267_91_0_1_1_00_1044480685.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_91_0_1_1_00_1044480685.raw
SUBJECT_SAMPLE_FACTORS           	WU8	1044480690	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=10; Age=32; RAW_FILE_NAME=KIT3-0-8115_1044482267_08_0_1_1_00_1044480690.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_08_0_1_1_00_1044480690.raw
SUBJECT_SAMPLE_FACTORS           	WM5	1044480701	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=7; Age=32; RAW_FILE_NAME=KIT3-0-8115_1044482267_20_0_1_1_00_1044480701.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_20_0_1_1_00_1044480701.raw
SUBJECT_SAMPLE_FACTORS           	PR12	1044480715	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=26; Age=39; RAW_FILE_NAME=KIT3-0-8115_1044482267_32_0_1_1_00_1044480715.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_32_0_1_1_00_1044480715.raw
SUBJECT_SAMPLE_FACTORS           	PR11	1044480720	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=8; Age=20; RAW_FILE_NAME=KIT3-0-8115_1044482267_44_0_1_1_00_1044480720.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_44_0_1_1_00_1044480720.raw
SUBJECT_SAMPLE_FACTORS           	Wu23	1044480734	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=26; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482267_56_0_1_1_00_1044480734.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_56_0_1_1_00_1044480734.raw
SUBJECT_SAMPLE_FACTORS           	WU26	1044480749	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=10; Age=32; RAW_FILE_NAME=KIT3-0-8115_1044482267_68_0_1_1_00_1044480749.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_68_0_1_1_00_1044480749.raw
SUBJECT_SAMPLE_FACTORS           	WU30	1044480753	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=15; Age=24; RAW_FILE_NAME=KIT3-0-8115_1044482267_80_0_1_1_00_1044480753.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_80_0_1_1_00_1044480753.raw
SUBJECT_SAMPLE_FACTORS           	WU28	1044480768	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=16; Age=31; RAW_FILE_NAME=KIT3-0-8115_1044482267_92_0_1_1_00_1044480768.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_92_0_1_1_00_1044480768.raw
SUBJECT_SAMPLE_FACTORS           	PR23	1044480772	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=7; Age=30; RAW_FILE_NAME=KIT3-0-8115_1044482267_09_0_1_1_00_1044480772.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_09_0_1_1_00_1044480772.raw
SUBJECT_SAMPLE_FACTORS           	WU4	1044480787	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=11; Age=35; RAW_FILE_NAME=KIT3-0-8115_1044482267_21_0_1_1_00_1044480787.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_21_0_1_1_00_1044480787.raw
SUBJECT_SAMPLE_FACTORS           	KA11	1044480791	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=6; Age=34; RAW_FILE_NAME=KIT3-0-8115_1044482267_33_0_1_1_00_1044480791.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_33_0_1_1_00_1044480791.raw
SUBJECT_SAMPLE_FACTORS           	KA1	1044480802	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=11; Age=34; RAW_FILE_NAME=KIT3-0-8115_1044482267_45_0_1_1_00_1044480802.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_45_0_1_1_00_1044480802.raw
SUBJECT_SAMPLE_FACTORS           	KA9	1044480817	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=13; Age=33; RAW_FILE_NAME=KIT3-0-8115_1044482267_57_0_1_1_00_1044480817.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_57_0_1_1_00_1044480817.raw
SUBJECT_SAMPLE_FACTORS           	KA19	1044480821	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=5; Age=27; RAW_FILE_NAME=KIT3-0-8115_1044482267_69_0_1_1_00_1044480821.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_69_0_1_1_00_1044480821.raw
SUBJECT_SAMPLE_FACTORS           	KA12	1044480836	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=11; Age=33; RAW_FILE_NAME=KIT3-0-8115_1044482267_81_0_1_1_00_1044480836.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_81_0_1_1_00_1044480836.raw
SUBJECT_SAMPLE_FACTORS           	KA5	1044480841	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=13; Age=26; RAW_FILE_NAME=KIT3-0-8115_1044482267_93_0_1_1_00_1044480841.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_93_0_1_1_00_1044480841.raw
SUBJECT_SAMPLE_FACTORS           	KA6	1044480855	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=7; Age=35; RAW_FILE_NAME=KIT3-0-8115_1044482267_10_0_1_1_00_1044480855.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_10_0_1_1_00_1044480855.raw
SUBJECT_SAMPLE_FACTORS           	KI1	1044480860	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=19; Age=41; RAW_FILE_NAME=KIT3-0-8115_1044482267_22_0_1_1_00_1044480860.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_22_0_1_1_00_1044480860.raw
SUBJECT_SAMPLE_FACTORS           	KI2	1044480874	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=11; Age=30; RAW_FILE_NAME=KIT3-0-8115_1044482267_34_0_1_1_00_1044480874.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_34_0_1_1_00_1044480874.raw
SUBJECT_SAMPLE_FACTORS           	KI16	1044480889	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=19; Age=21; RAW_FILE_NAME=KIT3-0-8115_1044482267_46_0_1_1_00_1044480889.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_46_0_1_1_00_1044480889.raw
SUBJECT_SAMPLE_FACTORS           	KI10	1044480893	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=20; Age=34; RAW_FILE_NAME=KIT3-0-8115_1044482267_58_0_1_1_00_1044480893.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_58_0_1_1_00_1044480893.raw
SUBJECT_SAMPLE_FACTORS           	KI20	1044480904	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=13; Age=28; RAW_FILE_NAME=KIT3-0-8115_1044482267_70_0_1_1_00_1044480904.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_70_0_1_1_00_1044480904.raw
SUBJECT_SAMPLE_FACTORS           	KI14	1044480919	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=10; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482267_82_0_1_1_00_1044480919.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_82_0_1_1_00_1044480919.raw
SUBJECT_SAMPLE_FACTORS           	RZ3	1044480923	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=25; Age=31; RAW_FILE_NAME=KIT3-0-8115_1044482267_94_0_1_1_00_1044480923.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_94_0_1_1_00_1044480923.raw
SUBJECT_SAMPLE_FACTORS           	RZ10	1044480938	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=21; Age=35; RAW_FILE_NAME=KIT3-0-8115_1044482267_11_0_1_1_00_1044480938.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_11_0_1_1_00_1044480938.raw
SUBJECT_SAMPLE_FACTORS           	RZ2	1044480942	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=10; Age=38; RAW_FILE_NAME=KIT3-0-8115_1044482267_23_0_1_1_00_1044480942.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_23_0_1_1_00_1044480942.raw
SUBJECT_SAMPLE_FACTORS           	PR29	1044480957	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=7; Age=35; RAW_FILE_NAME=KIT3-0-8115_1044482267_35_0_1_1_00_1044480957.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_35_0_1_1_00_1044480957.raw
SUBJECT_SAMPLE_FACTORS           	Wu1	1044480961	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=17; Age=30; RAW_FILE_NAME=KIT3-0-8115_1044482267_47_0_1_1_00_1044480961.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_47_0_1_1_00_1044480961.raw
SUBJECT_SAMPLE_FACTORS           	WU40	1044480976	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=15; Age=40; RAW_FILE_NAME=KIT3-0-8115_1044482267_59_0_1_1_00_1044480976.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_59_0_1_1_00_1044480976.raw
SUBJECT_SAMPLE_FACTORS           	KA13	1044480981	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=9; Age=30; RAW_FILE_NAME=KIT3-0-8115_1044482267_71_0_1_1_00_1044480981.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_71_0_1_1_00_1044480981.raw
SUBJECT_SAMPLE_FACTORS           	KA16	1044480995	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=6; Age=33; RAW_FILE_NAME=KIT3-0-8115_1044482267_83_0_1_1_00_1044480995.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_83_0_1_1_00_1044480995.raw
SUBJECT_SAMPLE_FACTORS           	KA3	1044481007	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=14; Age=36; RAW_FILE_NAME=KIT3-0-8115_1044482267_95_0_1_1_00_1044481007.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_95_0_1_1_00_1044481007.raw
SUBJECT_SAMPLE_FACTORS           	KI1.19	1044481011	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=14; Age=32; RAW_FILE_NAME=KIT3-0-8115_1044482267_12_0_1_1_00_1044481011.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_12_0_1_1_00_1044481011.raw
SUBJECT_SAMPLE_FACTORS           	KI3.19	1044481026	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=5; Age=21; RAW_FILE_NAME=KIT3-0-8115_1044482267_24_0_1_1_00_1044481026.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_24_0_1_1_00_1044481026.raw
SUBJECT_SAMPLE_FACTORS           	KI12	1044481031	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=13; Age=35; RAW_FILE_NAME=KIT3-0-8115_1044482267_36_0_1_1_00_1044481031.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_36_0_1_1_00_1044481031.raw
SUBJECT_SAMPLE_FACTORS           	PR2	1044481045	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=13; Age=35; RAW_FILE_NAME=KIT3-0-8115_1044482267_48_0_1_1_00_1044481045.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_48_0_1_1_00_1044481045.raw
SUBJECT_SAMPLE_FACTORS           	PR21	1044481050	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482252-1   1044482267-1; Cycle day=12; Age=19; RAW_FILE_NAME=KIT3-0-8115_1044482267_60_0_1_1_00_1044481050.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_60_0_1_1_00_1044481050.raw
SUBJECT_SAMPLE_FACTORS           	WU6	1044481064	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482252-1   1044482267-1; Cycle day=16; Age=33; RAW_FILE_NAME=KIT3-0-8115_1044482267_72_0_1_1_00_1044481064.raw; RAW_FILE_NAME=KIT2-0-8115_1044482252_72_0_1_1_00_1044481064.raw
SUBJECT_SAMPLE_FACTORS           	Wu41	1044481079	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=12; Age=45; RAW_FILE_NAME=KIT3-0-8115_1044482301_74_0_1_1_00_1044481079.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_74_0_1_1_00_1044481079.raw
SUBJECT_SAMPLE_FACTORS           	KI19	1044481083	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=24; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482301_86_0_1_1_00_1044481083.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_86_0_1_1_00_1044481083.raw
SUBJECT_SAMPLE_FACTORS           	KI7	1044481098	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=7; Age=28; RAW_FILE_NAME=KIT3-0-8115_1044482301_03_0_1_1_00_1044481098.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_03_0_1_1_00_1044481098.raw
SUBJECT_SAMPLE_FACTORS           	KI3	1044481109	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=10; Age=33; RAW_FILE_NAME=KIT3-0-8115_1044482301_15_0_1_1_00_1044481109.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_15_0_1_1_00_1044481109.raw
SUBJECT_SAMPLE_FACTORS           	Ki4.19	1044481113	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=26; Age=25; RAW_FILE_NAME=KIT3-0-8115_1044482301_27_0_1_1_00_1044481113.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_27_0_1_1_00_1044481113.raw
SUBJECT_SAMPLE_FACTORS           	RZ4	1044481128	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=11; Age=26; RAW_FILE_NAME=KIT3-0-8115_1044482301_39_0_1_1_00_1044481128.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_39_0_1_1_00_1044481128.raw
SUBJECT_SAMPLE_FACTORS           	RZ9	1044481132	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=8; Age=26; RAW_FILE_NAME=KIT3-0-8115_1044482301_51_0_1_1_00_1044481132.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_51_0_1_1_00_1044481132.raw
SUBJECT_SAMPLE_FACTORS           	PR14	1044481147	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=9; Age=39; RAW_FILE_NAME=KIT3-0-8115_1044482301_63_0_1_1_00_1044481147.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_63_0_1_1_00_1044481147.raw
SUBJECT_SAMPLE_FACTORS           	PR13	1044481151	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=26; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482301_75_0_1_1_00_1044481151.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_75_0_1_1_00_1044481151.raw
SUBJECT_SAMPLE_FACTORS           	PO6	1044481166	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=30; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482301_87_0_1_1_00_1044481166.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_87_0_1_1_00_1044481166.raw
SUBJECT_SAMPLE_FACTORS           	WM4	1044481171	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=16; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482301_04_0_1_1_00_1044481171.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_04_0_1_1_00_1044481171.raw
SUBJECT_SAMPLE_FACTORS           	PR31	1044481185	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=5; Age=24; RAW_FILE_NAME=KIT3-0-8115_1044482301_16_0_1_1_00_1044481185.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_16_0_1_1_00_1044481185.raw
SUBJECT_SAMPLE_FACTORS           	PO12	1044481190	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=10; Age=30; RAW_FILE_NAME=KIT3-0-8115_1044482301_28_0_1_1_00_1044481190.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_28_0_1_1_00_1044481190.raw
SUBJECT_SAMPLE_FACTORS           	KI4	1044481201	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=12; Age=37; RAW_FILE_NAME=KIT3-0-8115_1044482301_40_0_1_1_00_1044481201.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_40_0_1_1_00_1044481201.raw
SUBJECT_SAMPLE_FACTORS           	PR6	1044481215	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=10; Age=32; RAW_FILE_NAME=KIT3-0-8115_1044482301_52_0_1_1_00_1044481215.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_52_0_1_1_00_1044481215.raw
SUBJECT_SAMPLE_FACTORS           	PR3	1044481220	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=25; Age=27; RAW_FILE_NAME=KIT3-0-8115_1044482301_64_0_1_1_00_1044481220.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_64_0_1_1_00_1044481220.raw
SUBJECT_SAMPLE_FACTORS           	KA14	1044481234	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=9; Age=37; RAW_FILE_NAME=KIT3-0-8115_1044482301_76_0_1_1_00_1044481234.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_76_0_1_1_00_1044481234.raw
SUBJECT_SAMPLE_FACTORS           	WU32	1044481249	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=8; Age=28; RAW_FILE_NAME=KIT3-0-8115_1044482301_88_0_1_1_00_1044481249.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_88_0_1_1_00_1044481249.raw
SUBJECT_SAMPLE_FACTORS           	WU16	1044481253	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=10; Age=39; RAW_FILE_NAME=KIT3-0-8115_1044482301_05_0_1_1_00_1044481253.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_05_0_1_1_00_1044481253.raw
SUBJECT_SAMPLE_FACTORS           	WU33	1044481268	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=10; Age=27; RAW_FILE_NAME=KIT3-0-8115_1044482301_17_0_1_1_00_1044481268.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_17_0_1_1_00_1044481268.raw
SUBJECT_SAMPLE_FACTORS           	WU34	1044481272	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=17; Age=34; RAW_FILE_NAME=KIT3-0-8115_1044482301_29_0_1_1_00_1044481272.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_29_0_1_1_00_1044481272.raw
SUBJECT_SAMPLE_FACTORS           	WU7	1044481287	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=6; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482301_41_0_1_1_00_1044481287.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_41_0_1_1_00_1044481287.raw
SUBJECT_SAMPLE_FACTORS           	RZ7	1044481291	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=12; Age=33; RAW_FILE_NAME=KIT3-0-8115_1044482301_53_0_1_1_00_1044481291.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_53_0_1_1_00_1044481291.raw
SUBJECT_SAMPLE_FACTORS           	WU35	1044481302	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=10; Age=37; RAW_FILE_NAME=KIT3-0-8115_1044482301_65_0_1_1_00_1044481302.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_65_0_1_1_00_1044481302.raw
SUBJECT_SAMPLE_FACTORS           	PO4	1044481317	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=11; Age=30; RAW_FILE_NAME=KIT3-0-8115_1044482301_77_0_1_1_00_1044481317.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_77_0_1_1_00_1044481317.raw
SUBJECT_SAMPLE_FACTORS           	PO9	1044483039	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=20; Age=34; RAW_FILE_NAME=KIT3-0-8115_1044482301_89_0_1_1_00_1044483039.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_89_0_1_1_00_1044483039.raw
SUBJECT_SAMPLE_FACTORS           	PO10	1044483043	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=22; Age=39; RAW_FILE_NAME=KIT3-0-8115_1044482301_06_0_1_1_00_1044483043.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_06_0_1_1_00_1044483043.raw
SUBJECT_SAMPLE_FACTORS           	PO3	1044483058	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=11; Age=32; RAW_FILE_NAME=KIT3-0-8115_1044482301_18_0_1_1_00_1044483058.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_18_0_1_1_00_1044483058.raw
SUBJECT_SAMPLE_FACTORS           	PO13	1044483062	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=17; Age=28; RAW_FILE_NAME=KIT3-0-8115_1044482301_30_0_1_1_00_1044483062.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_30_0_1_1_00_1044483062.raw
SUBJECT_SAMPLE_FACTORS           	PO11	1044483077	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=16; Age=28; RAW_FILE_NAME=KIT3-0-8115_1044482301_42_0_1_1_00_1044483077.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_42_0_1_1_00_1044483077.raw
SUBJECT_SAMPLE_FACTORS           	PR24	1044483081	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=20; Age=20; RAW_FILE_NAME=KIT3-0-8115_1044482301_54_0_1_1_00_1044483081.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_54_0_1_1_00_1044483081.raw
SUBJECT_SAMPLE_FACTORS           	KI9	1044483096	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=10; Age=40; RAW_FILE_NAME=KIT3-0-8115_1044482301_66_0_1_1_00_1044483096.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_66_0_1_1_00_1044483096.raw
SUBJECT_SAMPLE_FACTORS           	PR20	1044483107	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=8; Age=40; RAW_FILE_NAME=KIT3-0-8115_1044482301_78_0_1_1_00_1044483107.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_78_0_1_1_00_1044483107.raw
SUBJECT_SAMPLE_FACTORS           	LO2	1044483111	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=5; Age=23; RAW_FILE_NAME=KIT3-0-8115_1044482301_90_0_1_1_00_1044483111.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_90_0_1_1_00_1044483111.raw
SUBJECT_SAMPLE_FACTORS           	LO7	1044483126	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=15; Age=35; RAW_FILE_NAME=KIT3-0-8115_1044482301_07_0_1_1_00_1044483126.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_07_0_1_1_00_1044483126.raw
SUBJECT_SAMPLE_FACTORS           	LO15	1044483131	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=14; Age=25; RAW_FILE_NAME=KIT3-0-8115_1044482301_19_0_1_1_00_1044483131.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_19_0_1_1_00_1044483131.raw
SUBJECT_SAMPLE_FACTORS           	KA25	1044483145	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=6; Age=30; RAW_FILE_NAME=KIT3-0-8115_1044482301_31_0_1_1_00_1044483145.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_31_0_1_1_00_1044483145.raw
SUBJECT_SAMPLE_FACTORS           	KA27	1044483150	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=7; Age=34; RAW_FILE_NAME=KIT3-0-8115_1044482301_43_0_1_1_00_1044483150.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_43_0_1_1_00_1044483150.raw
SUBJECT_SAMPLE_FACTORS           	WU31	1044483164	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=9; Age=27; RAW_FILE_NAME=KIT3-0-8115_1044482301_55_0_1_1_00_1044483164.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_55_0_1_1_00_1044483164.raw
SUBJECT_SAMPLE_FACTORS           	RZ8	1044483179	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=9; Age=28; RAW_FILE_NAME=KIT3-0-8115_1044482301_79_0_1_1_00_1044483179.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_79_0_1_1_00_1044483179.raw
SUBJECT_SAMPLE_FACTORS           	PR16	1044483183	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=4; Age=40; RAW_FILE_NAME=KIT3-0-8115_1044482301_91_0_1_1_00_1044483183.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_91_0_1_1_00_1044483183.raw
SUBJECT_SAMPLE_FACTORS           	PR10	1044483198	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=11; Age=31; RAW_FILE_NAME=KIT3-0-8115_1044482301_08_0_1_1_00_1044483198.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_08_0_1_1_00_1044483198.raw
SUBJECT_SAMPLE_FACTORS           	LO10	1044483209	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=10; Age=33; RAW_FILE_NAME=KIT3-0-8115_1044482301_20_0_1_1_00_1044483209.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_20_0_1_1_00_1044483209.raw
SUBJECT_SAMPLE_FACTORS           	LO20	1044483213	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=19; Age=39; RAW_FILE_NAME=KIT3-0-8115_1044482301_32_0_1_1_00_1044483213.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_32_0_1_1_00_1044483213.raw
SUBJECT_SAMPLE_FACTORS           	KA23	1044483228	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=8; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482301_44_0_1_1_00_1044483228.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_44_0_1_1_00_1044483228.raw
SUBJECT_SAMPLE_FACTORS           	Ki2.19	1044483232	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=19; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482301_56_0_1_1_00_1044483232.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_56_0_1_1_00_1044483232.raw
SUBJECT_SAMPLE_FACTORS           	PR18	1044483247	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=12; Age=28; RAW_FILE_NAME=KIT3-0-8115_1044482301_68_0_1_1_00_1044483247.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_68_0_1_1_00_1044483247.raw
SUBJECT_SAMPLE_FACTORS           	RZ6	1044483251	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=21; Age=28; RAW_FILE_NAME=KIT3-0-8115_1044482301_80_0_1_1_00_1044483251.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_80_0_1_1_00_1044483251.raw
SUBJECT_SAMPLE_FACTORS           	PR28	1044483266	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=5; Age=37; RAW_FILE_NAME=KIT3-0-8115_1044482301_92_0_1_1_00_1044483266.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_92_0_1_1_00_1044483266.raw
SUBJECT_SAMPLE_FACTORS           	KA28	1044483271	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=10; Age=32; RAW_FILE_NAME=KIT3-0-8115_1044482301_09_0_1_1_00_1044483271.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_09_0_1_1_00_1044483271.raw
SUBJECT_SAMPLE_FACTORS           	LO2	1044483285	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=5; Age=23; RAW_FILE_NAME=KIT3-0-8115_1044482301_21_0_1_1_00_1044483285.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_21_0_1_1_00_1044483285.raw
SUBJECT_SAMPLE_FACTORS           	LO4	1044483290	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=10; Age=34; RAW_FILE_NAME=KIT3-0-8115_1044482301_33_0_1_1_00_1044483290.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_33_0_1_1_00_1044483290.raw
SUBJECT_SAMPLE_FACTORS           	PO1	1044483301	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=14; Age=33; RAW_FILE_NAME=KIT3-0-8115_1044482301_45_0_1_1_00_1044483301.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_45_0_1_1_00_1044483301.raw
SUBJECT_SAMPLE_FACTORS           	PO2	1044483315	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=11; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482301_57_0_1_1_00_1044483315.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_57_0_1_1_00_1044483315.raw
SUBJECT_SAMPLE_FACTORS           	KI5	1044483320	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=17; Age=34; RAW_FILE_NAME=KIT3-0-8115_1044482301_69_0_1_1_00_1044483320.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_69_0_1_1_00_1044483320.raw
SUBJECT_SAMPLE_FACTORS           	KI8	1044483334	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=16; Age=30; RAW_FILE_NAME=KIT3-0-8115_1044482301_81_0_1_1_00_1044483334.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_81_0_1_1_00_1044483334.raw
SUBJECT_SAMPLE_FACTORS           	PR25	1044483349	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=5; Age=19; RAW_FILE_NAME=KIT3-0-8115_1044482301_93_0_1_1_00_1044483349.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_93_0_1_1_00_1044483349.raw
SUBJECT_SAMPLE_FACTORS           	PR15	1044483353	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=13; Age=39; RAW_FILE_NAME=KIT3-0-8115_1044482301_10_0_1_1_00_1044483353.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_10_0_1_1_00_1044483353.raw
SUBJECT_SAMPLE_FACTORS           	PR8	1044483368	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=21; Age=27; RAW_FILE_NAME=KIT3-0-8115_1044482301_22_0_1_1_00_1044483368.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_22_0_1_1_00_1044483368.raw
SUBJECT_SAMPLE_FACTORS           	WM1	1044483372	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=11; Age=41; RAW_FILE_NAME=KIT3-0-8115_1044482301_34_0_1_1_00_1044483372.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_34_0_1_1_00_1044483372.raw
SUBJECT_SAMPLE_FACTORS           	WM2	1044483387	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=16; Age=31; RAW_FILE_NAME=KIT3-0-8115_1044482301_46_0_1_1_00_1044483387.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_46_0_1_1_00_1044483387.raw
SUBJECT_SAMPLE_FACTORS           	WU12	1044483391	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=9; Age=40; RAW_FILE_NAME=KIT3-0-8115_1044482301_58_0_1_1_00_1044483391.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_58_0_1_1_00_1044483391.raw
SUBJECT_SAMPLE_FACTORS           	WU11	1044483402	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=11; Age=32; RAW_FILE_NAME=KIT3-0-8115_1044482301_70_0_1_1_00_1044483402.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_70_0_1_1_00_1044483402.raw
SUBJECT_SAMPLE_FACTORS           	PR30	1044482082	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=17; Age=33; RAW_FILE_NAME=KIT3-0-8115_1044482301_82_0_1_1_00_1044482082.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_82_0_1_1_00_1044482082.raw
SUBJECT_SAMPLE_FACTORS           	WU13	1044482097	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=11; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482301_94_0_1_1_00_1044482097.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_94_0_1_1_00_1044482097.raw
SUBJECT_SAMPLE_FACTORS           	WU14	1044482108	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=10; Age=34; RAW_FILE_NAME=KIT3-0-8115_1044482301_11_0_1_1_00_1044482108.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_11_0_1_1_00_1044482108.raw
SUBJECT_SAMPLE_FACTORS           	KI15	1044482112	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=13; Age=40; RAW_FILE_NAME=KIT3-0-8115_1044482301_23_0_1_1_00_1044482112.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_23_0_1_1_00_1044482112.raw
SUBJECT_SAMPLE_FACTORS           	KI18	1044482127	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=17; Age=26; RAW_FILE_NAME=KIT3-0-8115_1044482301_35_0_1_1_00_1044482127.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_35_0_1_1_00_1044482127.raw
SUBJECT_SAMPLE_FACTORS           	PR1	1044482131	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=8; Age=21; RAW_FILE_NAME=KIT3-0-8115_1044482301_47_0_1_1_00_1044482131.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_47_0_1_1_00_1044482131.raw
SUBJECT_SAMPLE_FACTORS           	KA2	1044482146	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=10; Age=38; RAW_FILE_NAME=KIT3-0-8115_1044482301_59_0_1_1_00_1044482146.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_59_0_1_1_00_1044482146.raw
SUBJECT_SAMPLE_FACTORS           	WU8	1044482151	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=10; Age=32; RAW_FILE_NAME=KIT3-0-8115_1044482301_71_0_1_1_00_1044482151.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_71_0_1_1_00_1044482151.raw
SUBJECT_SAMPLE_FACTORS           	WM5	1044482165	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=7; Age=32; RAW_FILE_NAME=KIT3-0-8115_1044482301_83_0_1_1_00_1044482165.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_83_0_1_1_00_1044482165.raw
SUBJECT_SAMPLE_FACTORS           	PR12	1044482170	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=26; Age=39; RAW_FILE_NAME=KIT3-0-8115_1044482301_95_0_1_1_00_1044482170.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_95_0_1_1_00_1044482170.raw
SUBJECT_SAMPLE_FACTORS           	PR11	1044482184	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=8; Age=20; RAW_FILE_NAME=KIT3-0-8115_1044482301_12_0_1_1_00_1044482184.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_12_0_1_1_00_1044482184.raw
SUBJECT_SAMPLE_FACTORS           	Wu23	1044482199	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=26; Age=29; RAW_FILE_NAME=KIT3-0-8115_1044482301_24_0_1_1_00_1044482199.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_24_0_1_1_00_1044482199.raw
SUBJECT_SAMPLE_FACTORS           	WU26	1044482200	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=10; Age=32; RAW_FILE_NAME=KIT3-0-8115_1044482301_36_0_1_1_00_1044482200.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_36_0_1_1_00_1044482200.raw
SUBJECT_SAMPLE_FACTORS           	WU30	1044482214	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=15; Age=24; RAW_FILE_NAME=KIT3-0-8115_1044482301_48_0_1_1_00_1044482214.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_48_0_1_1_00_1044482214.raw
SUBJECT_SAMPLE_FACTORS           	WU28	1044482229	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=16; Age=31; RAW_FILE_NAME=KIT3-0-8115_1044482301_60_0_1_1_00_1044482229.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_60_0_1_1_00_1044482229.raw
SUBJECT_SAMPLE_FACTORS           	PR23	1044482233	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Batch=1044482291-1   1044482301-1; Cycle day=7; Age=30; RAW_FILE_NAME=KIT3-0-8115_1044482301_72_0_1_1_00_1044482233.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_72_0_1_1_00_1044482233.raw
SUBJECT_SAMPLE_FACTORS           	WU4	1044482248	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Batch=1044482291-1   1044482301-1; Cycle day=11; Age=35; RAW_FILE_NAME=KIT3-0-8115_1044482301_84_0_1_1_00_1044482248.raw; RAW_FILE_NAME=KIT2-0-8115_1044482291_84_0_1_1_00_1044482248.raw
#COLLECTION
CO:COLLECTION_SUMMARY            	Peritoneal fluid was collected through aspiration using a Veress needle under
CO:COLLECTION_SUMMARY            	direct visualisation immediately upon introduction of the laparoscope to avoid
CO:COLLECTION_SUMMARY            	contamination with blood. The procedure was meticulously performed in line with
CO:COLLECTION_SUMMARY            	the standard operating procedures of the Endometriosis Phenome and Biobanking
CO:COLLECTION_SUMMARY            	Harmonisation Project. The collected peritoneal fluid was centrifuged at 1,000
CO:COLLECTION_SUMMARY            	× g for 10 min at 4 °C. The supernatant was transferred to a fresh 10 mL tube
CO:COLLECTION_SUMMARY            	(Sarstedt) and divided into 500 µL tubes. Blood samples were collected before
CO:COLLECTION_SUMMARY            	laparoscopy (before anaesthesia) in ethylenediaminetetraacetic acid (EDTA) 10 mL
CO:COLLECTION_SUMMARY            	tubes (Sarstedt). The time lapse between sample collection (both plasma and
CO:COLLECTION_SUMMARY            	peritoneal fluid) and processing was < 45 min. Blood samples were centrifuged at
CO:COLLECTION_SUMMARY            	2,500 × g for 10 min at 4 °C. Then, the plasma samples were split into 500 μL
CO:COLLECTION_SUMMARY            	aliquots. Both materials were stored at -80 °C until further use.
CO:COLLECTION_PROTOCOL_FILENAME  	Endometriosis_methods.pdf
CO:SAMPLE_TYPE                   	Plasma and Peritoneal fluid
CO:STORAGE_CONDITIONS            	-80℃
#TREATMENT
TR:TREATMENT_SUMMARY             	Biological material (plasma and peritoneal fluid) was obtained from women
TR:TREATMENT_SUMMARY             	undergoing laparoscopic surgery for the following reasons: ovarian cyst, pelvic
TR:TREATMENT_SUMMARY             	pain and/or infertility. The exclusion criteria were as follows: age under 18
TR:TREATMENT_SUMMARY             	and over 45 years old, irregular menstruation (< 25 or > 35 days), any form of
TR:TREATMENT_SUMMARY             	hormonal therapy during the last three months before surgery, pelvic
TR:TREATMENT_SUMMARY             	inflammatory disease, uterine fibroids, polycystic ovary syndrome, any
TR:TREATMENT_SUMMARY             	autoimmune diseases and malignant or suspected malignant. The details of the
TR:TREATMENT_SUMMARY             	study are described elsewhere [6]. The cycle phase was calculated from the last
TR:TREATMENT_SUMMARY             	menstrual period and average length of the menstrual cycle. Women from the
TR:TREATMENT_SUMMARY             	endometriosis group were diagnosed through laparoscopic findings, and each case
TR:TREATMENT_SUMMARY             	was histopathologically confirmed. As controls, we recruited patients without
TR:TREATMENT_SUMMARY             	visible endometriosis during laparoscopy. In this study we analysed plasma
TR:TREATMENT_SUMMARY             	samples obtained from 73 women with endometriosis and 35 controls and peritoneal
TR:TREATMENT_SUMMARY             	fluid samples obtained from 53 women with endometriosis and 34 controls. Women
TR:TREATMENT_SUMMARY             	from whom peritoneal fluid was collected represent the subgroup of patients from
TR:TREATMENT_SUMMARY             	whom plasma was collected. All women completed a World Endometriosis Research
TR:TREATMENT_SUMMARY             	Foundation clinical questionnaire and signed an informed consent form to
TR:TREATMENT_SUMMARY             	participate in the study. The Bioethics Committee operating at the Medical
TR:TREATMENT_SUMMARY             	University of Warsaw approved the collection of the material in accordance with
TR:TREATMENT_SUMMARY             	opinion No. KB 223/2017, issued on December 12, 2017. Diagnostic laparoscopy was
TR:TREATMENT_SUMMARY             	performed in all patients by trained gynaecologists. After surgery, each woman
TR:TREATMENT_SUMMARY             	diagnosed with endometriosis was assigned an appropriate stage of disease
TR:TREATMENT_SUMMARY             	advancement according to the revised American Fertility Society (rAFS)
TR:TREATMENT_SUMMARY             	classification.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Before analysis, all plasma and peritoneal fluid samples were thawed on ice,
SP:SAMPLEPREP_SUMMARY            	centrifuged at 2 750 g, 4°C for 5 min, and then vortexed for 15 min at 1200 RPM
SP:SAMPLEPREP_SUMMARY            	as advised by AbsoluteIDQ p180 kit instruction. AbsoluteIDQ p180 kit procedure
SP:SAMPLEPREP_SUMMARY            	started with the preparation of derivatization mixture, extraction, and FIA
SP:SAMPLEPREP_SUMMARY            	solvents. 10 µl of internal standard (IS) was put onto each 96-well plate.
SP:SAMPLEPREP_SUMMARY            	Afterward, 10 µl of the respective sample was pipetted into the previously
SP:SAMPLEPREP_SUMMARY            	assigned well. The plate was dried under a nitrogen stream using a Positive
SP:SAMPLEPREP_SUMMARY            	Pressure-96 Processor (Waters) for 30 min. At the end of the drying process, 50
SP:SAMPLEPREP_SUMMARY            	µl of derivatization mix was added to each well and left to derivatize for 25
SP:SAMPLEPREP_SUMMARY            	min at room temperature. The plate was further dried using a positive pressure
SP:SAMPLEPREP_SUMMARY            	manifold for 60 min. 300 µl of extraction solvent was added to each well, left
SP:SAMPLEPREP_SUMMARY            	to vortex at 450 RPM for 30 min, and then centrifuged at 500 g for 2 min to
SP:SAMPLEPREP_SUMMARY            	elute the extracted metabolites. 150 µl of eluted sample was transferred to a
SP:SAMPLEPREP_SUMMARY            	96-well LC plate, diluted with 150 µl of pure water, and 10 µl of eluted
SP:SAMPLEPREP_SUMMARY            	sample was transferred to a 96-well FIA plate and diluted with 490 µl of FIA
SP:SAMPLEPREP_SUMMARY            	solvent. Before injection, plates were vortexed at 600 RPM for 5 and 10 min,
SP:SAMPLEPREP_SUMMARY            	respectively.
SP:SAMPLEPREP_PROTOCOL_FILENAME  	Endometriosis_methods.pdf
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	Flow injection analysis using tandem mass spectrometry (FIA-MS/MS) analysis was
CH:CHROMATOGRAPHY_SUMMARY        	performed using Waters Acquity Ultra Performance Liquid Chromatography coupled
CH:CHROMATOGRAPHY_SUMMARY        	with Waters TQ-S triple-quadrupole mass spectrometer. Solvent B: 290mL methanol;
CH:CHROMATOGRAPHY_SUMMARY        	1 ampule FIA mobile phase additive
CH:CHROMATOGRAPHY_TYPE           	Flow induction analysis
CH:INSTRUMENT_NAME               	Waters Acquity
CH:COLUMN_NAME                   	No column
CH:SOLVENT_A                     	-
CH:SOLVENT_B                     	290mL methanol; 1 ampule (10 mL) FIA mobile phase additive
CH:FLOW_GRADIENT                 	100% B (0-2min)
CH:FLOW_RATE                     	total time 2.0 min, values in brackets are time points: 0.15mL/min
CH:FLOW_RATE                     	(0.05min)> 0.03mL/min (0.06min)> 0.03mL/min (1.1min)> 0.2mL/min (1.5min)>
CH:FLOW_RATE                     	0.8mL/min (1.6min)>0.8mL/min (1.85min)> 0.15mL/min (1.95min)> 0.15mL/min
CH:FLOW_RATE                     	(2.0min)
CH:COLUMN_TEMPERATURE            	-
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
AN:ANALYSIS_PROTOCOL_FILE        	Endometriosis_methods.pdf
#MS
MS:INSTRUMENT_NAME               	Waters Xevo-TQ-S
MS:INSTRUMENT_TYPE               	Triple quadrupole
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:MS_COMMENTS                   	The FIA extract was analyzed in positive mode to capture acylcarnitines,
MS:MS_COMMENTS                   	glycerophospholipids and sphingolipids, while hexoses were monitored in a
MS:MS_COMMENTS                   	subsequent run in negative mode. Data acquisition was made with the use of
MS:MS_COMMENTS                   	MassLynx 4.1 (Waters), TargetLynx XS 4.1 (Waters), and MetIDQ Oxygen-DB110-3005
MS:MS_COMMENTS                   	(Biocrates).
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	ng/ml
MS_METABOLITE_DATA_START
Samples	1044481404	1044481419	1044481423	1044481438	1044481442	1044481457	1044481461	1044481476	1044481481	1044481495	1044481506	1044481511	1044481714	1044481729	1044481733	1044481748	1044481752	1044481767	1044481771	1044481786	1044481791	1044481801	1044481816	1044481821	1044481835	1044481840	1044481854	1044481869	1044481873	1044481888	1044481892	1044481903	1044481918	1044481922	1044481937	1044481941	1044481956	1044481961	1044481994	1044482006	1044482011	1044482025	1044482030	1044482044	1044482059	1044482063	1044482078	1044481525	1044481530	1044481544	1044481559	1044481563	1044481578	1044481582	1044481597	1044481608	1044481612	1044481627	1044481631	1044481646	1044481651	1044481665	1044481670	1044481684	1044481699	1044481700	1044480564	1044480579	1044480583	1044480598	1044480609	1044480613	1044480628	1044480632	1044480647	1044480651	1044480666	1044480671	1044480685	1044480690	1044480701	1044480715	1044480720	1044480734	1044480749	1044480753	1044480768	1044480772	1044480787	1044480791	1044480802	1044480817	1044480821	1044480836	1044480841	1044480855	1044480860	1044480874	1044480889	1044480893	1044480904	1044480919	1044480923	1044480938	1044480942	1044480957	1044480961	1044480976	1044480981	1044480995	1044481007	1044481011	1044481026	1044481031	1044481045	1044481050	1044481064	1044481079	1044481083	1044481098	1044481109	1044481113	1044481128	1044481132	1044481147	1044481151	1044481166	1044481171	1044481185	1044481190	1044481201	1044481215	1044481220	1044481234	1044481249	1044481253	1044481268	1044481272	1044481287	1044481291	1044481302	1044481317	1044483039	1044483043	1044483058	1044483062	1044483077	1044483081	1044483096	1044483107	1044483111	1044483126	1044483131	1044483145	1044483150	1044483164	1044483179	1044483183	1044483198	1044483209	1044483213	1044483228	1044483232	1044483247	1044483251	1044483266	1044483271	1044483285	1044483290	1044483301	1044483315	1044483320	1044483334	1044483349	1044483353	1044483368	1044483372	1044483387	1044483391	1044483402	1044482082	1044482097	1044482108	1044482112	1044482127	1044482131	1044482146	1044482151	1044482165	1044482170	1044482184	1044482199	1044482200	1044482214	1044482229	1044482233	1044482248
Factors	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:IV | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:IV | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:II | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:II | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal	Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative
Hexose	644096.000	808696.000	695220.000	843680.000	781519.000	812400.000	805667.000	514342.000	536091.000	650989.000	711915.000	772221.000	594667.000	625799.000	576154.000	840879.000	787156.000	716085.000	801953.000	606673.000	663667.000	771609.000	520059.000	529766.000	680906.000	718686.000	735930.000	872484.000	685444.000	786108.000	562720.000	846763.000	790915.000	825043.000	560808.000	708583.000	693315.000	445566.000	705267.000	531499.000	854292.000	825099.000	477736.000	783953.000	585792.000	578819.000	686961.000	792913.000	559339.000	844114.000	790492.000	645933.000	176244.000	626650.000	504116.000	529944.000	655734.000	476292.000	702733.000	523718.000	749419.000	487570.000	491487.000	716675.000	573446.000	559938.000	744907.000	752272.000	822688.000	708824.000	1096982.000	843291.000	728760.000	648948.000	107118.000	663215.000	730340.000	612853.000	633623.000	411388.000	729158.000	787141.000	631744.000	689064.000	669001.000	654757.000	728855.000	629373.000	740721.000	601355.000	813687.000	713558.000	664233.000	829424.000	797056.000	887834.000	600137.000	750658.000	627193.000	745050.000	578950.000	521603.000	582503.000	577819.000	754808.000	543131.000	772096.000	729260.000	635278.000	345747.000	809310.000	688867.000	698755.000	834149.000	727517.000	650740.000	693318.000	675363.000	841405.000	858622.000	765202.000	860378.000	745676.000	707399.000	800346.000	782614.000	615326.000	1005567.000	648903.000	1471584.000	893003.000	753751.000	722264.000	578587.000	940138.000	832599.000	751563.000	846866.000	737525.000	869558.000	691868.000	840492.000	1313531.000	692681.000	880437.000	920819.000	634664.000	556773.000	707781.000	712445.000	740508.000	825794.000	605970.000	815402.000	917399.000	734628.000	762730.000	683208.000	820424.000	553993.000	767641.000	486232.000	688907.000	682912.000	787582.000	594147.000	997283.000	670475.000	749602.000	1087322.000	1108407.000	665875.000	626173.000	637396.000	704468.000	819293.000	601445.000	814420.000	1106985.000	842098.000	591714.000	855112.000	813137.000	850774.000	772481.000	638918.000	989394.000	724637.000	764796.000	1013632.000	800267.000	627906.000	731221.000	620388.000	720828.000	677372.000	679506.000
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	RefMet Name	WorkBench Metabolite_ID
Hexose	Hexose	ME907428
METABOLITES_END
#END